BIONTECH SE (BNTX)
Clinical trial NCT06712316 updates: 1. completion date: 2030-03-01 → 2031-12-01 2. primary completion date: 2029-02-01 → 2029-01-01 3. enrollment: 1260 → 1580 participants
Clinical trial NCT06712316 updates: 1. completion date: 2030-03-01 → 2031-12-01 2. primary completion date: 2029-02-01 → 2029-01-01 3. enrollment: 1260 → 1580 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical